ALKS,AZN,LLY,JNJ,PFE Zacks Analyst Blog Highlights: Alkermes, Inc ...   

Risperidone , which is marketed as Risperdal Consta, is Alkermes' lead product. Risperdal Consta is the longer-lasting injectable version of Johnson ......

risperdal </> LinkedWords™ - Contextually find and manage web ...   

Added: April 6, 2006, 5:33 am - Found in page: http://www.linkedwords.com/brands / johnson -- johnson / risperdal .php - Main site: www.linkedwords.com Opens in ......

Johnson RSS Blog Tags   

Dr. Biederman outlined plans to test Johnson & Johnson's drugs including risperidone /Risperidal in presentations to company executives and seemed to ......

Another FDA Setback for Johnson & Johnson (ELN, JNJ)   

Alkermes (Nasdaq: ALKS) receives manufacturing revenue and royalties from sales of Risperdal Consta, Johnson & Johnson's other extended-release ......

J&J Sales Rep Told Docs To Use Risperdal Off-Label // Pharmalot   

Oct 29, 2009 ... risperdal The admission came from Matt Thompson, a sales rep for Johnson & Johnson's Janssen unit, who testified in a trial over claims by a ......

Orange Book Blog: Teva Seeks Relisting of J&J's Risperdal Patent ...   

A reader recently e-mailed me about an interesting citizen petition that Teva filed last August. In the petition, Teva requests that FDA: (1) relist US ......

PRdomain.com | Johnson & Johnson | FDA Approves New Injection Site ...   

home > Johnson & Johnson > news. FDA Approves New Injection Site for RISPERDAL ® CONSTA® for Schizophrenia Treatment. 9 Oct 2008 , Titusville, ......

Global Insight // Same-Day Analysis   

J&J is likely to meet some cynicism from physicians over Invega because of its similarity to Risperdal . However, the company believes that the development ......

A Study of the Safety and Efficacy of Injectable Risperidone in ...   

Drug Information available for: Risperidone · U.S. FDA Resources. Further study details as provided by Johnson & Johnson Pharmaceutical Research ......

J&J says FDA rejects Risperdal as autism treatment | World of ...   

J&J says FDA rejects Risperdal as autism treatment Johnson & Johnson said on Friday US regulators rejected its application to market antipsychotic drug....

J&J to slash 7000 to 8000 jobs - Yahoo! News   

Nov 3, 2009 ... Cost savings have helped J&J cope with plunging sales of Risperdal and Topamax and to acquire stakes this year in Irish drugmaker Elan Corp ......

Off-Label Marketing; J&J Style - FDA - Zimbio   

Big Pharma Manufacturers Johnson & Johnson ( Risperdal ), Ely Lilly (Zyprexa), ... J&J has increased sales of Risperdal , in part, by increasing price. ......

Silobreaker: Risperdal   

First, Johnson & Johnson (NYSE: JNJ) is expected to launch Invega Sustenna, a long-acting, injectable antipsychotic that competes directly with Risperdal ......

Johnson & Johnson - Pharmaceutical Company Information   

Risperdal ( risperidone ) – Risperdal is the most often prescribed antipsychotic in the US and accounts for about $2.1 billion in sales to Johnson & Johnson . ......

Bipolar Disorder Daily News Blog: Johnson & Johnson Press Release ...   

Jun 22, 2007 ... Johnson & Johnson Press Release regarding Risperdal for Children and Adolescents with Bipolar Disorder and Schizophrenia ......

first   previous   1   2   3   4   next   last